Nitrofurantoin metabolite (CPAHD) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Nitrofurantoin metabolite (CPAHD) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to food safety diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-78-11. BSA-Nitrofurantoin metabolite (CPAHD)
2. Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody
$2709.00
GMP-SMT-78-21. OVA-Nitrofurantoin metabolite (CPAHD)
2. Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody
$2709.00
GMP-SMT-78-31. BSA-Nitrofurantoin metabolite (CPAHD)
2. Anti-Nitrofurantoin metabolite (CPAHD) human monoclonal antibody
$2709.00
GMP-SMT-78-41. OVA-Nitrofurantoin metabolite (CPAHD)
2. Anti-Nitrofurantoin metabolite (CPAHD) human monoclonal antibody
$2709.00
GMP-SMT-78-Ag-1BSA-Nitrofurantoin metabolite (CPAHD)$756.00
GMP-SMT-78-Ag-2OVA-Nitrofurantoin metabolite (CPAHD)$756.00
GMP-SMT-78-Ab-1Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody$1953.00
GMP-SMT-78-Ab-2Anti-Nitrofurantoin metabolite (CPAHD) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Nitrofurantoin metabolite (CPAHD)

Cat No.GMP-SMT-78-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Nitrofurantoin metabolite (CPAHD) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Nitrofurantoin metabolite (CPAHD) had been validated with our anti-Hapten antibody Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Nitrofurantoin metabolite (CPAHD)

Cat No.GMP-SMT-78-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Nitrofurantoin metabolite (CPAHD) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Nitrofurantoin metabolite (CPAHD) had been validated with our anti-Hapten antibody Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Nitrofurantoin metabolite (CPAHD) mouse monoclonal antibody

Cat No.GMP-SMT-78-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.50
Products descriptionThe anti-Hapten antibody against hapten Nitrofurantoin metabolite (CPAHD) had been validated with our hapten hapten-carrier conjugates BSA-Nitrofurantoin metabolite (CPAHD) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Nitrofurantoin metabolite (CPAHD) human monoclonal antibody

Cat No.GMP-SMT-78-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.50
Products descriptionThe anti-Hapten antibody against hapten Nitrofurantoin metabolite (CPAHD) had been validated with our hapten hapten-carrier conjugates BSA-Nitrofurantoin metabolite (CPAHD) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Biomarker Information


    Basic Orange (BO/CSD) is a type of basic dye that falls under the xanthene family. It is commonly used in various industrial sectors, including textiles, paper manufacturing, and plastic production, as a coloring agent. The chemical structure of BO/CSD consists of a pyridine ring with different substituents attached to it, which can vary based on specific applications and desired properties.

    The use of BO/CSD in industrial processes has raised concerns regarding its potential impact on both the environment and human health. When released into the environment, BO/CSD can enter water bodies through wastewater discharges, leaching from landfills, or accidental spills. This can lead to contamination of aquatic ecosystems, soil, and potentially even groundwater sources.

    One of the major concerns surrounding BO/CSD is its environmental persistence and resistance to degradation. Due to these characteristics, BO/CSD has the potential to persist in the environment for a long time, accumulating in various compartments and potentially causing adverse effects on ecosystems. Additionally, its resistance to degradation means that it may not easily break down into less harmful substances over time.

    Studies have indicated that BO/CSD can have toxic effects on aquatic organisms, such as fish and algae. Exposure to BO/CSD can result in behavioral changes, reduced growth rates, and even reproductive impairments in these organisms. Furthermore, the presence of BO/CSD in surface water can disrupt the balance of the ecosystem, leading to cascading effects on other species within the food chain.

    In addition to its potential environmental impacts, BO/CSD also raises concerns about human health risks. Prolonged exposure to BO/CSD has been linked to skin irritation, respiratory problems, and other health issues. Some studies have also suggested that the breakdown products of BO/CSD in the environment may be more toxic than the original dye itself, posing additional risks to human health.

    To mitigate the potential risks associated with BO/CSD, it is crucial to regularly monitor its levels in environmental samples. Monitoring BO/CSD concentrations in surface water, sediment, and biota helps to identify pollution sources and evaluate the effectiveness of pollution control measures. It also aids in the development of appropriate management strategies to minimize inputs of BO/CSD into the environment and mitigate its potential impacts.

    Various analytical techniques can be used to detect and quantify BO/CSD concentrations in environmental samples. These techniques include fluorescence spectroscopy, spectrophotometry, and high-performance liquid chromatography (HPLC). These methods provide accurate and precise measurements of BO/CSD levels in different environmental matrices, enabling the evaluation of potential risks associated with BO/CSD contamination.

    In conclusion, Basic Orange (BO/CSD) is a commonly used basic dye in various industries, but it raises concerns regarding its potential impact on both the environment and human health. Ongoing monitoring of BO/CSD levels in environmental samples is essential for identifying pollution sources, assessing the effectiveness of pollution control measures, and implementing strategies to minimize potential risks. The use of analytical techniques plays a critical role in quantifying BO/CSD concentrations and providing valuable information to regulatory agencies, enabling them to safeguard public health and protect ecosystems. Implementing sustainable practices and exploring safer alternatives can help reduce the potential risks associated with BO/CSD and other hazardous dyes in industrial processes.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.